摘要
通过分析丙肝病毒(HCV) 的非结构4 区(NS4) 和5 区(NS5)蛋白的氨基酸序列,推测确定抗原决定簇位点。用RT- PCR 技术从中国丙肝病人血清中扩增克隆含抗原决定簇基因的NS4 及NS5 基因,将该两段基因分别克隆至质粒表达载体pET28a( + ) 内,转化大肠杆菌BL21(DE3) ,构建成功了高效表达NS4 和NS5 蛋白的工程菌,IPTG 诱导后两蛋白在工程菌内的表达量分别约占菌体蛋白的33 % 和28 % 。经Sepharcryl S- 200 分子筛及Ni- NTASepharose 螯合层析纯化,获得了较纯的重组NS4 和NS5 蛋白。用纯化的NS4 和NS5 蛋白作抗原ELISA 法检测HCV抗体阴、阳性血清,证实它们有较好的抗原性和特异性。
The NS 4 and NS 5 gene fragments of hepatitis C virus were cloned from anti HCV positive sera by RT PCR, the recombinant plasmids expressing NS 4 or NS 5protein were constructed by inserting the cloned NS 4 or NS 5 gene fragments into plasmid vector pET28a(+), the expressed NS 4 protein is about 33% of total host ( E.coli BL21) proteins, and the NS 5 is about 28%. After purification, the expressed NS 4 and NS 5 protein were used to detect 87 anti HCV (anti HCV core and or NS 3 antigen) positive sera and 160 anti HCV(anti core and NS 3 antigens) negative sera, of the 87 positive sera, 28 (31%) sera are anti NS 4 positive and 62(70%) sera are anti NS 5positive; of the 160 negative sera, 2 sera are anti NS 4 weak positive and 1 serum is anti NS 5 weak positive. The results suggest that the NS 4 and NS 5 proteins have excellent antigenicity and specificity, and may increase the detection rate of anti HCV when being added in ELISA kit for detection of anti HCV.
出处
《药物生物技术》
CAS
CSCD
1999年第4期198-202,共5页
Pharmaceutical Biotechnology
基金
全军青年基金!课题:编号96Q12
关键词
HCV
非结构区蛋白
基因表达
蛋白纯化
抗原
Hepatitis C virus, Non structural protein, Gene expression, Protein purification